Skip to main content

Post-IPO Debt Therapeutics Companies

Explore 28 therapeutics startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
28
Total Funding
$287.0M
Avg Funding
$95.7M
Cities
3

Export 28 Post-IPO Debt Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Mölndal, Sweden
$37.0M
raised

Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$50.0M
raised

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Nov 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Waltham, United States
$200.0M
raised

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 26 to 28 of 28 companies

Ready to Connect with Post-IPO Debt Therapeutics Startups?

Get verified founder emails, funding details, and company data for 28 post-ipo debt therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

28 Therapeutics Post-IPO Debt Startups (September 2026) — Page 2 | VCBacked